Post by nateb on May 31, 2016 13:19:49 GMT
Just saw this: finance.yahoo.com/news/stemcells-terminates-mid-stage-study-123651879.html Sad news for the investors, employees and patients. I wonder if NVIV will buy some of the IP for their upcoming Chronic SCI study.